The participants in the study were over the age of 18 and had been diagnosed with at least one mental health condition. The results suggested that many participants felt that microdosing was more effective than some other types of conventional treatment, yet not as effective as standard doses of psychedelics. As its popularity rises, it’s important to remember that the short and long-term effects of microdosing are still largely unknown. Many factors, including your current mental and physical health condition, play a role in the effects of psychedelics. If you or a loved one are considering microdosing, speak with your healthcare provider and/or a mental health provider about your risks.
Strengths, limitations and future directions
Longer term, we found evidence that microdosing led to improved mental health, altered attentional capacities (reduced mind wandering and increased absorption), and increased neuroticism. Expectations can affect human behaviour in a range of ways, including influencing hypnotic responses 98 increasing sensory attenuation 99, and enhancing mindfulness 100. Expectations can also have particularly profound impacts on drug effects, even amongst individuals with no prior experience of a particular substance 101. Study One recruited participants from online communities that share and discuss media and personal accounts of microdosing that are mainly very positive. Participation in these communities may lead to specific expectations that shape individuals’ experiences of microdosing. Most of the early research on microdosing has not included a control group or explicitly investigated participant expectations (although see 23).
The reasonfor suggesting these equivalence studies is that of the several hundred thousandpeople known to have microdosed, less than 1% of them actually used the GMP gradepsilocybin. If their experiences differ from those using the synthetic substance, agreat deal of otherwise correlative data would need to be put aside. In peripheral tissues, very low doses of psychedelics have profound anti-inflammatoryeffects (Yu et al.,2008).
- Proponents of microdosing claim that taking these psychedelics in small, measured doses benefits the mind, making them think more clearly or feel more open throughout the day.
- TikTok led the way as the number one source for microdosing advice, with Instagram, Reddit, and X close behind.
- Therefore, the substantial anecdotal support for microdosing, notably their reported lack of relative side effects, cannot be reliably concluded.
- Additionally, researchers may want to vary the frequency of doses within a study, ranging from frequent (Cameron et al. 2019) to infrequent administration, (Ross et al. 2016) and aim to design longitudinal studies to determine the long-term effects of practicing microdosing.
- The second study found that most participants had high expectations about microdosing’s potential benefits.
It is important to mention that the use of all psychedelic drugs should be undertaken with utmost caution — if they should be used at all — in patients with major mental illness such as schizophrenia or bipolar disorder. For safety reasons, these patients are typically excluded from studies involving psychedelic drugs. Based on responses taken at baseline, this sample was experienced with psychedelics but reported relatively moderate experience with other drugs. Specifically, 6 participants (9.5%) reported using psychedelics more than once a week, 14 (22.2%) used psychedelics a few times a month, 33 (52.4%) a few times a year, and 10 (15.9%) had no prior experience of psychedelics. We also asked participants about their use of 3,4-methylenedioxymethamphetamine (MDMA), methamphetamine, opiates and other similar drugs (excluding cannabis).
While many may challenge this scheduling, the fact remains that these substances are illegal to possess or consume in most cases. People with a history of psychotic disorders, such as bipolar disorder, schizophrenia, or other disorders, may also want to avoid microdosing, as the practice may be too stimulating. More research is still necessary to not only determine whether microdosing is helpful, but if they are safe in the long-term. However, a combination of other factors, such as stress reduction or increased focus, may lead to this benefit. Others may microdose using other psychedelics, such as N,N-dimethyltryptamine (DMT) or the cactus peyote, though these seem to be less popular and may be harder to come by.
In a test traditionally used to measure the efficacy of antidepressants, rats treated with DMT exhibited antidepressant-like responses without any impairment to working or short-term memory or social interaction. This study corroborates reports that microdosing in humans alleviates depressive-like symptoms 2. However, anxiety reduction, enhanced sociability, and enhanced cognitive function self-reported by users in the study conducted by Hutten et al. (2019) was not observed. To conclude, this study demonstrates that microdosing is mostly used to enhance performance.
It is concluded that while most anecdotal reports focus on the positiveexperiences with microdosing, future research should also focus on potentialrisks of (multiple) administrations of a psychedelic in low doses. To thatend, (pre)clinical studies including biological (e.g. heart rate, receptorturnover and occupancy) as well as cognitive (e.g. memory, attention)parameters have to be conducted and will shed light on the potentialnegative consequences microdosing could have. The main risks of psychedelic microdosing include mental health concerns, physical side effects, developing tolerance and dependency on psychedelics, and physical health risks. A 2020 study by Cameron, L. P., et al. “Chronic, Intermittent Microdoses of the Psychedelic N,N-Dimethyltryptamine (DMT) Produce Positive Effects on Mood and Anxiety in Rodents Without Impacting Cognition” published in Frontiers in Psychology outlines these potential risks of microdosing. Other prominent motives included facilitating learning and creativity, and promoting health behaviors.
Lesser known risks of microdosing include:
- I would recommend not mentioning just these very few anecdotal cases in respectto creativity and psychedelics.
- As such, there may be a bit of bias in these studies, as the people may expect to have a good experience while microdosing.
- Methodological details of the included experimental studies with low doses of LSD.
- However, a cultural shift in recreational psychedelic drug usage during the 1960s and 1970s led to a relabeling of psychedelic drugs.
In other words, they are subject to the most extremerestrictions and penalties for unapproved possession. These constraints apply to anydose of the drug, even a sub-psychoactive or microdose level. Research can becarried out with the right ethical regulatory and institutional approvals, butdosing would have to be conducted in a secure environment like a hospital orresearch ward. For repeated microdosing, this adds significant costs and complexityto any study, which is likely why none have yet been reported.
About Medical News Today
The review article points out that therehas only been one published trial that specifically examined the effects ofpsilocybin microdosing. This was an open-label, non-controlled trial, with uncertaindoses of psilocybin ingested, that was conducted without ethical approval. Itreported on improvements in two creativity-related problem-solving tasks followingrecreational psilocybin microdosing (Prochazkova et al., 2018). A limitation ofthe present article is the focus on psilocybin even though online fora suggest thatrecreational LSD microdosing may be as common (if not more so) than psilocybinmicrodosing (, 2019). By not focusing equally on LSD microdosing, the article does notcapture the most rigorously conducted and peer-reviewed published trial ofmicrodosing to date.
This approach shows promise in mental health treatment, as even small amounts induce feelings of well-being and emotional clarity without the full dissociative effects experienced at higher doses. Microdosing is the practice of consuming very low doses of psychedelic substances to achieve subtle cognitive or emotional benefits rather than experiencing full psychedelic effects. Unlike traditional psychedelic use, which typically involves consuming a full dose to induce a profound hallucinogenic and spiritual experience, microdosing is intended to enhance day-to-day functioning without noticeable intoxication. Another study published in the journal Frontiers in Psychiatry asked participants via an online questionnaire microdosing long term effects about their experiences with microdosing.
Product Reviews
The most reported regular and microdose for LSD was 200 mcg and 10 mcg, and for psilocybin 3.5 g and 0.5 g, respectively. However, most respondents (up to 67%) indicated not knowing the dosage they normally consume. In addition, one-half of the respondents (48.9%) that microdosed followed their own microdosing schedule. The majority of respondents who microdosed with LSD and psilocybin (57–78%) reported using microdosing several times per week, ranging between 2 and 4 times per week, respectively. One-half of the microdosers (47.6%) indicated to have microdosed while working, of which studying and computer/office work were the most prevalent daily occupations. The motives to microdose in descending order were for performance enhancement (37%), mood enhancement (29%), out of curiosity (15%), and for self-medication (14%).
While they are rare and often may not hold as much weight as the perks, it is important to be aware of them and retain objectivity in analyzing your own experiences. Many people share the idea that microdosing with psychedelics enhances one’s mood, creativity, concentration, productivity, and ability to empathize with others. This means that most people who take a daily pill that they fervently expect will help them feel happier and smarter will feel like they are happier and smarter — just from taking the pill, regardless of what’s in it. Some of the domains which did not change in Study One (e.g., creativity and quality of life) are very commonly described in media stories on the effects of microdosing 96,97. Conversely, some domains that did change in Study One (e.g., absorption, neuroticism) are not typically mentioned in media stories on microdosing. This indicates that common media narratives may not match up with people’s experiences when measured in a systematic way.
When administered to healthy individuals in a supportive setting, both psilocybin 30–33 and LSD 34, have been shown to elicit mystical-type experiences that are characterised as highly meaningful and transformative by participants. Psilocybin 35 and LSD 36 have also both been shown to bias emotional processing toward positive information and to attenuate responses to fearful stimuli. In addition psilocybin has been shown to increase emotional empathy 37, whereas LSD has been shown to increase feelings of well-being, closeness to others and trust 38; increase emotional response and personal meaningfulness to music 39,40; and increase suggestibility 41.
However, among working adults, taking low doses of psychedelics has recently gained popularity in its ability to boost productivity, reduce anxiety and depression, and enhance overall well-being. Only a few studies have investigated these benefits in a controlled, randomized setting, all of which produced promising results. However, the data is far from sufficient, and significant further study is warranted before psychedelics may become a mainstream nootropic supplement. Another study in Frontiers in Psychiatry used an online questionnaire to ask people who microdose to compare its effects with those of other treatments for symptoms such as depression and anxiety. The answers indicated that people found microdosing more effective than some other forms of treatment but less effective than higher doses of psychedelics.
The American Psychological Association estimates that more than 12 percent of the U.S. population over the age of 12 takes antidepressant medications (e.g., Prozac, Zoloft, Wellbutrin). Antidepressants are modest in their overall efficacy, and while many individuals find that their symptoms may improve with these medicines, they may also introduce a host of unpleasant side effects. One notable side effect is withdrawal after long-term use, which has led to discussion about how antidepressants may be altering brain architecture and chemistry over these long stretches of time. Some may take antidepressant medication for a year, while others have been on them for well over a decade. This effect that both substances have in common seems to be responsible for glutamate cell activity in the frontal cortex. Going further, scientists speculate that this transmission is the cause of the “higher-level cognitive, perceptual, and affective distortions” we experience under the effect.
By signing up, you agree to the Terms of Use and Privacy Policy & to receive electronic communications from VICE Media Group, which may include marketing promotions, advertisements and sponsored content. For starters, belief is so important to the experience that empty capsules can produce the same effects. He grows his own mushrooms in Olympia, Washington, where psilocybin has been decriminalized. “I started microdosing and within a couple of months, I had a general sense of well-being that I hadn’t had in so long,” said Marine Corps combat veteran Matt Metzger. In a perfect world, I think we would microdose LSD instead of giving teenagers Adderall.